Sandoz Group AG

Common Name

Sandoz Group

Country

Switzerland

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

20,000

Ticker

SDZ

Exchange

SIX SWISS EXCHANGE

Website

www.sandoz.com

Description

Sandoz Group AG is a global leader in the pharmaceuticals industry, specializing in the development and manufacture of generic drugs and biosimilars. The company, part of the Novartis Group until its ... Show more

Financial Statements of Sandoz Group

Below are the financial statements of Sandoz Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Assets	—	—
Property, plant and equipment	1,695^a	1,585^a
Right-of-use assets	293^a	265^a
Goodwill	7,469^a	7,589^a
Intangible assets other than goodwill	1,475^a	1,562^a
Deferred tax assets	954^a	716^a
Financial assets	60^a	41^a
Other non-current assets	160^a	100^a
Total non-current assets	12,106^a	11,858^a
Inventories	2,800^a	2,700^a
Trade receivables	2,205^a	2,615^a
Income tax receivables	309^a	321^a
Derivative financial instruments	15^a	35^a
Cash and cash equivalents	1,191^a	1,109^a
Other current assets	1,281^a	736^a
Total current assets without assets held for sale	7,801^a	7,516^a
Assets held for sale	0^a	56^a
Total current assets	7,801^a	7,572^a
Total assets	19,907^a	19,430^a
Liabilities	—	—
Financial debts	4,390^a	3,975^a
Lease liabilities	276^a	255^a
Deferred tax liabilities	259^a	252^a
Provisions and other non-current liabilities	511^a	596^a
Total non-current liabilities	5,436^a	5,078^a
Trade payables	1,519^a	1,593^a
Financial debts and derivative financial instruments	145^a	284^a
Lease liabilities	58^a	54^a
Current income tax liabilities	510^a	572^a
Provisions and other current liabilities	4,075^a	3,160^a
Total current liabilities without liabilities held for sale	6,307^a	5,663^a
Liabilities held for sale	0^a	35^a
Total current liabilities	6,307^a	5,698^a
Total liabilities	11,743^a	10,776^a
Equity	—	—
Share capital	25^a	24^a
Treasury shares	-1^a	0^a
Reserves	8,139^a	8,621^a
Equity attributable to the shareholders of Sandoz Group AG	8,163^a	8,645^a
Non-controlling interests	1^a	9^a
Total equity	8,164^a	8,654^a
Total liabilities and equity	19,907^a	19,430^a

Download Data

Verified Sources Behind Sandoz Group’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sandoz Group’s data sources below and access millions more through our Disclosure Search.

a. Sandoz Group's Integrated Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Sandoz Group AG

Financial Statements of Sandoz Group

Verified Sources Behind Sandoz Group’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Siegfried Holding AG

Galderma Group AG

Sonova Holding AG

Tecan Group AG

BeOne Medicines AG

Roche Holding AG